University of Minnesota Masonic Cancer Center Logo
Print this page.Mail this link to a friend.

Find a Clinical Trial


Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Hematologic malignancies Clinical Trials

Protocol Number Title
1999LS060
MT1999-14 Unrelated or partially matched allogeneic donor stem cells for lymphoma, myeloma, and chronic lymphocytic leukemia
2001LS058
MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy
2004LS006
MT2003-15 Use of Cyclophosphamide/Fludarabine to Promote in vivo Expansion of Donor Lymphocyte Infusion s(DLI) to Enhance Efficacy after Allogeneic Transplant
2005LS023
MT2004-30: Dose Escalation of Total Marrow Irradiation Added To An Alkylator-Intense Conditioning Regimen For Patients with High Risk or Relapsed Solid Tumors
2005LS036
MT2005-02: Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Non-Myeloablative Preparative Regimen
2005LS043
MT2005-10: Transplantation of Unrelated Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloblative Preparative Regimen
2005LS048
MT2004-24: Autologous Peripheral Blood Stem Cell Transplant for Patients with Lymphoma
2006NT036
MT2007-16R Pilot Study of Vascular Function During Hematopoietic Cell Transplantation
2007CG049
COG AHOD03P1: Treatment of Children with Newly Diagnosed Low Stage Lymphocyte Predominant Hodgkin Disease (LPHD)
2007NT092
AHOD04B1 Hodgkin's Disease Banking Study
2007NT123
2007-18R: Chronic GVHD Cohort Protocol
2008CG099
MT2008-30: A Multi-Center, Phase II Trial of Non-Myeloablative Conditioning (NST) and Transplantation of Umbilical Cord Blood (UCB) from Unrelated Donors in Patients with Hematologic Malignancies (2008-30)
2008LS112
A Therapeutic Trial of Decitabine (Dacogen) and Vorinostat (SAHA) in Combination with Chemotherapy (Vincristine, Prednisone, Doxorubicin and PEG-Asparaginase) for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) MT2008-29R
2008LS139
MT2008-38: A Phase I Trial to Determine Safety and Tolerability of Ex Vivo Expanded Human Myeloid Progenitor Cells (CLT-008) Infused 24 Hours Post-Transplant to Support Allogeneic Umbilical Cord Blood Transplantation for Hematologic Malignancies
2008NTCG161
COG ACCL0731 Glutamic Acid to Decrease Vincristine Toxicity in Children with Cancer
2009NTCG002
Pilot Study of Financial impact of Allogeneic Stem Cell Transplant

16 trials displayed